Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
405.4 DKK | -0.50% | -3.43% | +9.27% |
10/05 | NOVONESIS : Key segments outperform in average Q1 24 showing | |
03/05 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.27% | 2.71TCr | |
+11.09% | 178.98Cr | |
-7.28% | 66Cr | |
-26.05% | 40Cr | |
-81.65% | 22Cr | |
-13.42% | 11Cr | |
-25.36% | 5.02Cr |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes A/S Announces Executive Appointments, Effective April 2021